Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

442
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
442
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

649
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
649
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

580
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
580

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Upfront Effectiveness of a 6-Week Continuous Glucose Monitoring Intervention for Non-Insulin-Using Individuals With Type 2 Diabetes Is No Longer Detectable at 6-12 Months: An Observational Follow-Up of a Randomized Trial Cohort.

Diabetes, obesity & metabolism·2026
Same author

Mitral annular calcification in high-risk patients: to operate or not to operate.

Journal of thoracic disease·2026
Same author

In T2D inadequately controlled with metformin, orforglipron reduced HbA<sub>1c</sub> more than oral semaglutide at 52 wk.

Annals of internal medicine·2026
Same author

Radiologic reporting of DeBakey type I aortic dissection: key preoperative and postoperative findings of the AMDS hybrid stent.

Journal of thoracic disease·2026
Same author

The impact of perfusate filtration or exchange on lung function during ex vivo lung perfusion (EVLP): a systematic review.

Journal of thoracic disease·2026
Same author

Transcatheter Aortic Valve Replacement in a Perceval Valve: Pitfalls, Tips, and Outcomes.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026

Related Experiment Video

Updated: Apr 23, 2026

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats
06:32

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats

Published on: June 28, 2019

7.6K

Resource Use Following Revascularization for Multivessel Coronary Artery Disease.

Ryaan El-Andari1, Jimmy Kang1, Nicholas Fialka1

  • 1Division of Cardiac Surgery, Department of Surgery University of Alberta Edmonton AB Canada.

Journal of the American Heart Association
|April 22, 2026
PubMed
Summary

Coronary artery bypass grafting (CABG) is more cost-effective and leads to fewer adverse events than percutaneous coronary intervention (PCI) for severe coronary artery disease. CABG reduces hospital readmissions and repeat procedures, improving patient outcomes and lowering healthcare costs.

Keywords:
coronary artery bypass graftingcoronary artery diseasepercutaneous coronary interventionreadmissionresource use

More Related Videos

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA
13:10

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA

Published on: April 24, 2017

17.6K
Author Spotlight: Enhancing Coronary Artery Revascularization
05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

1.4K

Related Experiment Videos

Last Updated: Apr 23, 2026

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats
06:32

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats

Published on: June 28, 2019

7.6K
Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA
13:10

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA

Published on: April 24, 2017

17.6K
Author Spotlight: Enhancing Coronary Artery Revascularization
05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

1.4K

Area of Science:

  • Cardiovascular Medicine
  • Health Economics
  • Interventional Cardiology

Background:

  • Coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) are primary revascularization methods for severe coronary artery disease.
  • Previous cost-effectiveness analyses of CABG versus PCI in multivessel disease have yielded conflicting results due to limitations in sample size, follow-up duration, and contemporary data.

Purpose of the Study:

  • To compare the cost-effectiveness and resource utilization of CABG and PCI in patients with severe coronary artery disease.
  • To evaluate long-term outcomes, including adverse events and healthcare costs, associated with CABG and PCI.

Main Methods:

  • A retrospective analysis of resource use following elective, urgent, or emergent PCI or CABG between January 1, 2009, and December 31, 2018.
  • Utilized a provincial database for data collection and Canadian Institute of Health Information data for cost calculations, adjusted for inflation.
  • Assessed costs for readmission and repeat revascularization, with secondary outcomes including death, myocardial infarction, rehospitalization, and repeat revascularization rates.

Main Results:

  • Of 7,359 patients included, those undergoing PCI incurred significantly higher overall costs ($19,165 per person) compared to CABG ($12,612 per person).
  • Patients treated with PCI exhibited higher rates of death, myocardial infarction, rehospitalization, and repeat revascularization (P<0.001).

Conclusions:

  • Coronary artery bypass grafting (CABG) is associated with fewer adverse events and lower healthcare resource utilization post-discharge compared to percutaneous coronary intervention (PCI) for multivessel coronary artery disease.
  • Optimizing the selection between CABG and PCI can potentially decrease readmissions and healthcare expenditures following revascularization procedures.